These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 9125470

  • 1. Antiserum to activity-dependent neurotrophic factor produces neuronal cell death in CNS cultures: immunological and biological specificity.
    Gozes I, Davidson A, Gozes Y, Mascolo R, Barth R, Warren D, Hauser J, Brenneman DE.
    Brain Res Dev Brain Res; 1997 Apr 18; 99(2):167-75. PubMed ID: 9125470
    [Abstract] [Full Text] [Related]

  • 2. Activity-dependent neurotrophic factor: structure-activity relationships of femtomolar-acting peptides.
    Brenneman DE, Hauser J, Neale E, Rubinraut S, Fridkin M, Davidson A, Gozes I.
    J Pharmacol Exp Ther; 1998 May 18; 285(2):619-27. PubMed ID: 9580606
    [Abstract] [Full Text] [Related]

  • 3. Activity-dependent neurotrophic factor: intranasal administration of femtomolar-acting peptides improve performance in a water maze.
    Gozes I, Giladi E, Pinhasov A, Bardea A, Brenneman DE.
    J Pharmacol Exp Ther; 2000 Jun 18; 293(3):1091-8. PubMed ID: 10869414
    [Abstract] [Full Text] [Related]

  • 4. A femtomolar-acting neuroprotective peptide induces increased levels of heat shock protein 60 in rat cortical neurons: a potential neuroprotective mechanism.
    Zamostiano R, Pinhasov A, Bassan M, Perl O, Steingart RA, Atlas R, Brenneman DE, Gozes I.
    Neurosci Lett; 1999 Apr 02; 264(1-3):9-12. PubMed ID: 10320001
    [Abstract] [Full Text] [Related]

  • 5. VIP neurotrophism in the central nervous system: multiple effectors and identification of a femtomolar-acting neuroprotective peptide.
    Brenneman DE, Glazner G, Hill JM, Hauser J, Davidson A, Gozes I.
    Ann N Y Acad Sci; 1998 Dec 11; 865():207-12. PubMed ID: 9928014
    [Abstract] [Full Text] [Related]

  • 6. Activity-dependent neurotrophic factor-14 requires protein kinase C and mitogen-associated protein kinase kinase activation to protect the developing mouse brain against excitotoxicity.
    Gressens P, Marret S, Bodénant C, Schwendimann L, Evrard P.
    J Mol Neurosci; 1999 Dec 11; 13(1-2):199-210. PubMed ID: 10691306
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. VIP and peptides related to activity-dependent neurotrophic factor protect PC12 cells against oxidative stress.
    Steingart RA, Solomon B, Brenneman DE, Fridkin M, Gozes I.
    J Mol Neurosci; 2000 Dec 11; 15(3):137-45. PubMed ID: 11303778
    [Abstract] [Full Text] [Related]

  • 10. Complete sequence of a novel protein containing a femtomolar-activity-dependent neuroprotective peptide.
    Bassan M, Zamostiano R, Davidson A, Pinhasov A, Giladi E, Perl O, Bassan H, Blat C, Gibney G, Glazner G, Brenneman DE, Gozes I.
    J Neurochem; 1999 Mar 11; 72(3):1283-93. PubMed ID: 10037502
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Activity-dependent neurotrophic factor-derived peptide prevents alcohol-induced apoptosis, in part, through Bcl2 and c-Jun N-terminal kinase signaling pathways in fetal brain of C57BL/6 mouse.
    Sari Y, Weedman JM, Ge S.
    Neuroscience; 2012 Jan 27; 202():465-73. PubMed ID: 22178609
    [Abstract] [Full Text] [Related]

  • 13. Mapping the active site in vasoactive intestinal peptide to a core of four amino acids: neuroprotective drug design.
    Gozes I, Perl O, Giladi E, Davidson A, Ashur-Fabian O, Rubinraut S, Fridkin M.
    Proc Natl Acad Sci U S A; 1999 Mar 30; 96(7):4143-8. PubMed ID: 10097177
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Vasoactive intestinal peptide (VIP) prevents neurotoxicity in neuronal cultures: relevance to neuroprotection in Parkinson's disease.
    Offen D, Sherki Y, Melamed E, Fridkin M, Brenneman DE, Gozes I.
    Brain Res; 2000 Jan 31; 854(1-2):257-62. PubMed ID: 10784133
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Cyclosporine induces neuronal apoptosis and selective oligodendrocyte death in cortical cultures.
    McDonald JW, Goldberg MP, Gwag BJ, Chi SI, Choi DW.
    Ann Neurol; 1996 Nov 31; 40(5):750-8. PubMed ID: 8957016
    [Abstract] [Full Text] [Related]

  • 19. K-252a and staurosporine promote choline acetyltransferase activity in rat spinal cord cultures.
    Glicksman MA, Prantner JE, Meyer SL, Forbes ME, Dasgupta M, Lewis ME, Neff N.
    J Neurochem; 1993 Jul 31; 61(1):210-21. PubMed ID: 8515268
    [Abstract] [Full Text] [Related]

  • 20. NAP and ADNF-9 protect normal and Down's syndrome cortical neurons from oxidative damage and apoptosis.
    Busciglio J, Pelsman A, Helguera P, Ashur-Fabian O, Pinhasov A, Brenneman DE, Gozes I.
    Curr Pharm Des; 2007 Jul 31; 13(11):1091-8. PubMed ID: 17430172
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.